InsidersTradesSigma
Track the 대웅제약 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 대웅제약 has recorded 2 reports. Market capitalisation: €1,460.1bn. The latest transaction was filed on 27 March 2026 (Sale). Among the most active insiders: 대웅. Every trade is free.
Analysts rate 대웅제약 Buy (bullish), based on 9 analysts. Average price target: ₩207,778.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Daewoong Pharmaceutical is a South Korean pharmaceutical company focused on the development and manufacturing of medications. It is listed on the XKRX.